Emergency contraception in the iPLEDGE program: A cross-sectional survey of pediatric dermatology provider understanding and practice.
Publication/Presentation Date
9-1-2022
Abstract
For patients with acne treated with the teratogen isotretinoin, emergency contraception (EC) is the only recourse when abstinence fails or effective contraception is not properly used. The purpose of this study was to evaluate the current understanding and provision of EC among pediatric dermatology providers. The survey found that 37% (21/57) of providers indicated they were at least somewhat confident in their understanding of EC. 7% (4/57) of providers agreed/strongly agreed that they provided EC counseling to all patients of reproductive potential at their initial visit and 3.5% (2/57) agreed/strongly agreed that they provide EC counseling at follow-up visits. Our survey results suggest the need for improved EC education for pediatric dermatology providers and subsequent counseling for patients of reproductive potential on isotretinoin therapy.
Volume
39
Issue
5
First Page
727
Last Page
730
ISSN
1525-1470
Published In/Presented At
Smiley, C. E., Butt, M., & Zaenglein, A. L. (2022). Emergency contraception in the iPLEDGE program: A cross-sectional survey of pediatric dermatology provider understanding and practice. Pediatric dermatology, 39(5), 727–730. https://doi.org/10.1111/pde.15086
Disciplines
Medicine and Health Sciences
PubMedID
35918308
Department(s)
Department of Medicine
Document Type
Article